Home > Qtrly Results > NEULAND LABORATORIES

NEULAND LABORATORIES
Quarterly Results Analysis [Sep2025]

NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Quarterly Results

Consolidated Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Revenues ₹514 Cr ₹293 Cr ₹328 Cr ₹398 Cr ₹311 Cr ₹440 Cr ₹385 Cr ₹393 Cr
Expenses ₹359 Cr ₹258 Cr ₹277 Cr ₹311 Cr ₹249 Cr ₹316 Cr ₹278 Cr ₹272 Cr
Operating Income ₹156 Cr ₹34 Cr ₹51 Cr ₹87 Cr ₹62 Cr ₹123 Cr ₹107 Cr ₹121 Cr
Other Income ₹2 Cr ₹8 Cr ₹7 Cr ₹4 Cr ₹4 Cr ₹5 Cr ₹5 Cr ₹2 Cr
Interest ₹5 Cr ₹5 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹3 Cr ₹4 Cr ₹4 Cr
Depreciation ₹23 Cr ₹20 Cr ₹17 Cr ₹16 Cr ₹16 Cr ₹16 Cr ₹16 Cr ₹15 Cr
Profit Before Tax ₹129 Cr ₹18 Cr ₹39 Cr ₹128 Cr ₹49 Cr ₹130 Cr ₹92 Cr ₹104 Cr
Profit After Tax ₹97 Cr ₹14 Cr ₹28 Cr ₹102 Cr ₹33 Cr ₹98 Cr ₹68 Cr ₹81 Cr
EPS ₹75.07 ₹10.77 ₹21.56 ₹78.75 ₹25.46 ₹75.86 ₹52.37 ₹63.09
Industry Peers & Returns1W1M1Y
NEULAND LABORATORIES -1.6% -7.3% 6.4%
SUN PHARMACEUTICAL INDUSTRIES -2.7% -2.2% -0.8%
DIVIS LABORATORIES -0.7% -1.1% 7.6%
CIPLA -1.2% -1.8% 3.4%
TORRENT PHARMACEUTICALS -0.8% 0.8% 12.2%
DR REDDYS LABORATORIES NA 2.4% 0.2%
MANKIND PHARMA -1.7% -3.6% -21.6%
ZYDUS LIFESCIENCES -1.6% -1.8% -7.1%
LUPIN 0.2% 4.6% 2.5%

NEULAND LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

75.67 %

Y-o-Y

65.44 %

Quarters Revenues % Change
Sep2025 ₹514 Cr
75.67
Jun2025 ₹293 Cr
-10.84
Mar2025 ₹328 Cr
-17.50
Dec2024 ₹398 Cr
28.05
Sep2024 ₹311 Cr
-29.29
Jun2024 ₹440 Cr
14.18
Mar2024 ₹385 Cr
-1.99
Dec2023 ₹393 Cr -

NEULAND LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

351.00 %

Y-o-Y

149.96 %

Quarters Operating Profit % Change
Sep2025 ₹156 Cr
351.00
Jun2025 ₹34 Cr
-32.47
Mar2025 ₹51 Cr
-41.02
Dec2024 ₹87 Cr
39.16
Sep2024 ₹62 Cr
-49.56
Jun2024 ₹123 Cr
15.38
Mar2024 ₹107 Cr
-11.83
Dec2023 ₹121 Cr -
Operating Margins
Q-o-Q

156.79 %

Y-o-Y

51.10 %

Quarters Operating Margin% % Change
Sep2025 30.25%
156.79
Jun2025 11.78%
-24.24
Mar2025 15.55%
-28.54
Dec2024 21.76%
8.69
Sep2024 20.02%
-28.65
Jun2024 28.06%
1.04
Mar2024 27.77%
-10.04
Dec2023 30.87% -

NEULAND LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

596.85 %

Y-o-Y

194.90 %

Quarters Profit After Tax % Change
Sep2025 ₹97 Cr
596.85
Jun2025 ₹14 Cr
-50.01
Mar2025 ₹28 Cr
-72.63
Dec2024 ₹102 Cr
209.31
Sep2024 ₹33 Cr
-66.44
Jun2024 ₹98 Cr
44.87
Mar2024 ₹68 Cr
-16.99
Dec2023 ₹81 Cr -
PAT Margins
Q-o-Q

296.42 %

Y-o-Y

78.15 %

Quarters PAT Margin(%) % Change
Sep2025 18.83 %
296.42
Jun2025 4.75 %
-43.92
Mar2025 8.47 %
-66.81
Dec2024 25.52 %
141.44
Sep2024 10.57 %
-52.52
Jun2024 22.26 %
26.84
Mar2024 17.55 %
-15.30
Dec2023 20.72 % -

NEULAND LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

597.03 %

Y-o-Y

194.85 %

Quarters EPS % Change
Sep2025 ₹75.07
597.03
Jun2025 ₹10.77
-50.05
Mar2025 ₹21.56
-72.62
Dec2024 ₹78.75
209.31
Sep2024 ₹25.46
-66.44
Jun2024 ₹75.86
44.85
Mar2024 ₹52.37
-16.99
Dec2023 ₹63.09 -

You may also like the below Video Courses